Question 1

What's the Glaxosmithkline Pharmaceuticals Ltd share price today?

Accepted Answer

Glaxosmithkline Pharmaceuticals Ltd share price was Rs 2,424.90 at 04:01 PM IST on 17th Mar 2026. Glaxosmithkline Pharmaceuticals Ltd share price was up by 0.82% over the previous closing price of Rs 2,405.15. Glaxosmithkline Pharmaceuticals Ltd share price trend:

Last 1 Month: Glaxosmithkline Pharmaceuticals Ltd share price moved down by 6.76% on BSE
Last 3 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved down by 5.89% on BSE
Last 12 Months: Glaxosmithkline Pharmaceuticals Ltd share price moved down by 9.76% on BSE
Last 3 Years: Glaxosmithkline Pharmaceuticals Ltd price moved up by 88.61% on BSE

Question 2

How can I quickly analyse the performance of the Glaxosmithkline Pharmaceuticals Ltd stock?

Accepted Answer

The performance of the Glaxosmithkline Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 40.31
Price to book value ratio is 24.10
Dividend yield of 2.22
The EPS (trailing 12 months) of the Glaxosmithkline Pharmaceuticals Ltd stock is Rs 60.27

Question 3

What is the market cap of Glaxosmithkline Pharmaceuticals Ltd?

Accepted Answer

Glaxosmithkline Pharmaceuticals Ltd has a market capitalisation of Rs 41,080 crore.

Question 4

What is Glaxosmithkline Pharmaceuticals Ltd's 52-week high/low share price?

Accepted Answer

The Glaxosmithkline Pharmaceuticals Ltd’s 52-week high share price is Rs 3,515.95 and 52-week low share price is Rs 2,220.00.

Question 5

Is the Glaxosmithkline Pharmaceuticals Ltd profitable?

Accepted Answer

On a consolidated basis, Glaxosmithkline Pharmaceuticals Ltd reported a profit of Rs 295.62 crore on a total income of Rs 1,091.36 crore for the quarter ended 2025. For the year ended Dec 2025, Glaxosmithkline Pharmaceuticals Ltd had posted a profit of Rs 295.62 crore on a total income of Rs 1,091.36 crore.

Question 6

Which are Glaxosmithkline Pharmaceuticals Ltd’s peers in the Health care sector?

Accepted Answer

Glaxosmithkline Pharmaceuticals Ltd’s top 5 peers in the Health care sector are  Glenmark Pharma., Abbott India, Laurus Labs, Glaxosmi. Pharma, Ipca Labs., Ajanta Pharma, Anthem Bioscienc.

Question 7

Who owns how much in Glaxosmithkline Pharmaceuticals Ltd?

Accepted Answer

Key changes to the Glaxosmithkline Pharmaceuticals Ltd shareholding are as follows:

Promoter holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 75.00 per cent as of Dec 2025 from 75.00 per cent as of Mar 2025.
Indian Public holding in Glaxosmithkline Pharmaceuticals Ltd has gone down to 10.36 per cent as of Dec 2025 from 10.60 per cent as of Mar 2025.
Mutual Funds Uti holding in Glaxosmithkline Pharmaceuticals Ltd has gone down to 4.77 per cent as of Dec 2025 from 5.17 per cent as of Mar 2025.
Foreign Institutional Investors holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 4.64 per cent as of Dec 2025 from 4.52 per cent as of Mar 2025.
Insurance Companies holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 2.65 per cent as of Dec 2025 from 2.58 per cent as of Mar 2025.
Non Institutional Investors holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 2.30 per cent as of Dec 2025 from 2.09 per cent as of Mar 2025.
Other Institutional Investors holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 0.27 per cent as of Dec 2025 from 0.03 per cent as of Mar 2025.
Financial Institutions holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 0.01 per cent as of Dec 2025 from 0.01 per cent as of Mar 2025.
Custodians holding in Glaxosmithkline Pharmaceuticals Ltd has gone up to 0.00 per cent as of Dec 2025 from 0.00 per cent as of Mar 2025.

Market Cap (₹ Cr)	41,080
Traded Value (₹ Cr)	0.48
Volume (Shares)	1,980
Face Value (₹)	10

52-Week High (₹)	3,515.95
52-Week High Date	05-Jun-2025
52-Week Low (₹)	2,220.00
52-Week Low Date	21-Jan-2026

All Time High (₹)	3,515.95
All Time High Date	05-Jun-2025
All Time Low (₹)	12.88
All Time Low Date	19-Aug-1988

Glaxosmithkline Pharmaceuticals Share Price

Glaxosmithkline Pharmaceuticals Ltd